Home › Cardiomyopathy › Minnesota
Cardiomyopathy clinical trials in Minnesota
8 studies for Cardiomyopathy are looking for participants at sites in Minnesota.
Cities in Minnesota
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Rochester
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Clinical Course Of Disease In Participants With FA-CM
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 6 and older · All sexes · Updated Sep 2, 2026 · NCT06865482Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Mayo Clinic - Rochester, Rochester
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
- Mayo Clinic, Rochester
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 30, 2026 · NCT07137338Mayo AVC Registry and Biobank
- Mayo Clinic, Rochester
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Apr 27, 2026 · NCT03049254A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT07308704MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Mayo Clinic, Rochester
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629Genetic Markers of Cardiovascular Disease in Epilepsy
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 18 to 50 · All sexes · Updated Sep 8, 2025 · NCT02824822From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.